Literature DB >> 9422264

The potential role of proton beams in radiation oncology.

J S Loeffler1, A R Smith, H D Suit.   

Abstract

Historically, major gains in the local control of large, deep-seated tumors treated with radiation have occurred whenever dose distributions have become more localized to the tumor. Better dose localization permits the delivery of higher tumor doses while delivering less dose to dose-limiting normal tissues. High-energy protons, because they stop abruptly in tissue at the end of their range and deposit most of their energy there, provide dose distributions that are superior to x-rays when used in comparable beam configurations. The installation of a hospital-based proton therapy facility at the Massachusetts General Hospital in Boston, MA, and the existing facility at Loma Linda University Medical Center, Loma Linda, CA, provide a potential for achieving higher rates of local control in tumors throughout the body.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9422264

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  6 in total

1.  A challenge for high-precision radiation therapy: the case for photons.

Authors:  R A Gahbauer
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

2.  Whole-body proton irradiation causes long-term damage to hematopoietic stem cells in mice.

Authors:  Jianhui Chang; Wei Feng; Yingying Wang; Yi Luo; Antiño R Allen; Igor Koturbash; Jennifer Turner; Blair Stewart; Jacob Raber; Martin Hauer-Jensen; Daohong Zhou; Lijian Shao
Journal:  Radiat Res       Date:  2015-01-30       Impact factor: 2.841

Review 3.  Gastrointestinal radiation injury: prevention and treatment.

Authors:  Abobakr K Shadad; Frank J Sullivan; Joseph D Martin; Laurence J Egan
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

Review 4.  Standard and novel radiotherapeutic approaches to neoplastic meningitis.

Authors:  Eric L Chang; Moshe H Maor
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

Review 5.  Prevention and treatment of radiotherapy-induced side effects.

Authors:  Lara Barazzuol; Rob P Coppes; Peter van Luijk
Journal:  Mol Oncol       Date:  2020-06-24       Impact factor: 6.603

Review 6.  Ionizing Particle Radiation as a Modulator of Endogenous Bone Marrow Cell Reprogramming: Implications for Hematological Cancers.

Authors:  Sujatha Muralidharan; Sharath P Sasi; Maria A Zuriaga; Karen K Hirschi; Christopher D Porada; Matthew A Coleman; Kenneth X Walsh; Xinhua Yan; David A Goukassian
Journal:  Front Oncol       Date:  2015-10-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.